Saturday, March 29, 2014 9:42:26 AM
I'm still waiting to wake-up one morning and turn on CNN and find Gerald being interviewed about LymPro.
p.s. I hope you didn't sell yesterday.
Along with the "tweet" from Gerald these are two more reasons the share price recovered on Friday:
The Life Sciences Report – “From Lab Bench to Bedside: David Lowe Brings Common Sense to Neuroscience Investing”
http://www.thelifesciencesreport.com/pub/na/from-lab-bench-to-bedside-david-lowe-brings-common-sense-to-neuroscience-investing
How Alzheimer’s Blood Test Could Paradoxically Change the Long-Term Care Market
http://seekingalpha.com/article/2114603-how-alzheimers-blood-tests-could-paradoxically-free-the-long-term-care-market
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
